LDHA and neoplasm: Immunostaining for these HFSC markers showed that tumors generated from HFSCs do indeed continue to express Sox9 and CD34, and that this is not affected by loss of Ldha. Hypoxia is a common phenotype in a majority of malignant tumors and has been shown to alter tumor metabolism, vascularization, and epithelial-to-mesenchymal transition.